Eterna Therapeutics
ERNA
#10319
Rank
C$13.79 M
Marketcap
C$1.76
Share price
-2.29%
Change (1 day)
-67.35%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2025 (TTM): C-$103.97

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is C-$105.37. In 2022 the company made an earnings per share (EPS) of C-$172.86 an increase over its 2021 EPS that were of C-$1,142.

EPS history for Eterna Therapeutics from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$103.97
2022C-$172.86-84.86%
2021C-$1,142

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Baxter
BAX
C-$0.91-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
C-$0.16-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
C-$2.77-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$5.09-104.83%๐Ÿ‡ซ๐Ÿ‡ท France
Bio-Techne
TECH
C$0.69-100.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
C$0.87-100.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel